News

Filter

Ranbaxy launches Lulifin, in-licensed from Summit Pharmaceuticals, in India

05-01-2010

Indian drug maker Ranbaxy Laboratories, which is majority owned by Japan’s Daiichi Sankyo, has launched…

Antibiotics and Infectious diseasesAsia-PacificDaiichi SankyoDermatologicalsPharmaceuticalRanbaxy LaboratoriesSankyo

Back to top